A multicenter, randomized, prospective study of 14 days ranitidine bismuth citrate vs. lansoprazole based triple therapies for the eradication of Helicobacter pylori in dyspeptic patients.
dc.contributor.author | Tiftikci, A | |
dc.contributor.author | Avsar, E | |
dc.contributor.author | KAYMAKOĞLU, Sabahattin | |
dc.contributor.author | Erzin, Y | |
dc.contributor.author | Poturoglu, S | |
dc.contributor.author | Dincer, D | |
dc.contributor.author | Yildirim, B | |
dc.contributor.author | Guliter, S | |
dc.contributor.author | Turkay, C | |
dc.contributor.author | Onuk, MD | |
dc.contributor.author | Yilmaz, U | |
dc.contributor.author | Bolukbas, C | |
dc.contributor.author | ELLİDOKUZ, ENDER BERAT | |
dc.contributor.author | Bektas, A | |
dc.contributor.author | Kocakaya, O | |
dc.contributor.author | Ates, Y | |
dc.date.accessioned | 2022-02-18T11:01:19Z | |
dc.date.available | 2022-02-18T11:01:19Z | |
dc.identifier.citation | Avsar E., KAYMAKOĞLU S., Erzin Y., Poturoglu S., Dincer D., Tiftikci A., Yildirim B., Guliter S., Turkay C., Onuk M., et al., "A multicenter, randomized, prospective study of 14 days ranitidine bismuth citrate vs. lansoprazole based triple therapies for the eradication of Helicobacter pylori in dyspeptic patients.", Annual Meeting of the American-Gastroenterological-Association/Digestive-Disease-Week, Illinois, Amerika Birleşik Devletleri, 14 - 19 Mayıs 2005, cilt.128 | |
dc.identifier.other | av_cfc1112a-56e3-495a-8089-447aa0555301 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/180347 | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Klinik Tıp | |
dc.subject | GASTROENTEROLOJİ VE HEPATOLOJİ | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Gastroenteroloji-(Hepatoloji) | |
dc.subject | Gastroenterology | |
dc.subject | Hepatology | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Health Sciences | |
dc.subject | Tıp | |
dc.title | A multicenter, randomized, prospective study of 14 days ranitidine bismuth citrate vs. lansoprazole based triple therapies for the eradication of Helicobacter pylori in dyspeptic patients. | |
dc.type | Bildiri | |
dc.contributor.department | , , | |
dc.identifier.volume | 128 | |
dc.contributor.firstauthorID | 3373128 |
Bu öğenin dosyaları:
Dosyalar | Boyut | Biçim | Göster |
---|---|---|---|
Bu öğe ile ilişkili dosya yok. |
Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.
-
Bildiri [64839]